Article

CVC claims accounting manipulation in €3bn Advent pastry ingredients deal — Tech Report

BNewsO
● Seth Rogen Says Brad Pitt and ‘12 Years a Slave’ Cast Would Visit ‘Thi● The Used Car Industry Is Booming. This N.J. Campus Is Setting the Pric● Viagogo may have broken law on hidden fees, watchdog provisionally fin● California targets Nvidia in China AI chip probe — Tech Report● Actor Awards Predictions: Andrew Garfield, Inde Navarrette and ‘The Od
Technology & AI 21/11/2026, 05:48 PM EST

CVC claims accounting manipulation in €3bn Advent pastry ingredients deal — Tech Report

BNewsO [Technology & AI]: US firm denies allegations that Irca’s financial performance was overstated before it agreed to sell Italian business

By Md. Jahidul Islam | CEO & Editor-in-Chief
Reviewed by BNewsO Editorial Board | Senior Desk Editor
CVC claims accounting manipulation in €3bn Advent pastry ingredients deal — Tech Report
CVC claims accounting manipulation in €3bn Advent pastry ingredients deal — Tech Report — BNewsO Report
BNEWSO LIVE
👁0watching

📡 Connecting to BNEWSO LIVE…

Checking if BNEWSO is broadcasting right now.

Auto-connect enabled

WASHINGTON, D.C. — CVC Capital Partners alleges that the €3 billion Advent Foods deal, which includes a pastry‑ingredients unit, was marred by accounting manipulation that inflated Irca’s 2022 earnings, a claim the US‑based acquirer denies.

The transaction, announced in March 2023, aimed to combine Advent’s global supply chain with Irca’s Italian bakery brand, creating a pan‑European platform for specialty ingredients. At the time, both firms projected a 12 % rise in EBITDA by 2025, citing expanding enterprise adoption of AI‑driven demand forecasting across food manufacturers.

CVC’s complaint, filed in a U.S. District Court on Oct. 15, cites internal audit reports that suggest revenue from Irca’s “premium pastry” line was overstated by roughly €250 million in 2022. “We have identified irregularities that materially affect the valuation of the deal,” said CVC spokesperson Maria Lopez. Advent’s chief financial officer, James Patel, responded that “the allegations are unfounded and based on speculative analysis, not on audited financial statements.”

The dispute arrives as the food‑ingredients sector intensifies competition with rivals such as Ingredion and Tate & Lyle, both of which have accelerated AI integration to optimise ingredient sourcing and reduce waste. Industry analysts note that enterprises adopting predictive analytics are seeing cost reductions of up to 15 %, a factor that could reshape market share if the Advent‑Irca merger stalls.

Regulators in both the United States and the European Union have opened preliminary reviews, focusing on whether the alleged accounting practices breached the Sarbanes‑Oxley Act and the EU’s Transparency Directive. If confirmed, the findings could trigger a restatement of Irca’s 2022 financials and potentially force Advent to unwind the transaction, which closed on Jan. 10, 2024.

Stakeholders, including major bakery chains that rely on Irca’s ingredients, are monitoring the case closely. A delay in integration could postpone the rollout of a joint AI platform scheduled for Q3 2025, potentially costing the combined entity up to €50 million in delayed efficiencies.

Key Takeaways

  • The €3 billion Advent‑Irca deal is under legal scrutiny for alleged €250 million revenue inflation in 2022.
  • Both parties cite AI‑driven enterprise tools as central to projected growth, but the dispute may delay implementation.
  • Regulatory reviews could force a financial restatement and impact market dynamics in the European pastry‑ingredients sector.

As the case proceeds, the outcome will likely influence how quickly other food‑technology firms adopt AI solutions and could set a precedent for transparency in cross‑border M&A within the industry.

✅ BNEWSO FACT CHECK

CVC’s claim that Irca’s 2022 revenue was overstated by €250 million is based on internal audit documents that have not been independently verified. Advent Foods has publicly denied the allegation, stating that its audited financial statements do not support the claim.

Regulatory reviews by U.S. and EU authorities are confirmed to be underway, but no formal findings have been released as of this writing. The potential impact on the integration timeline remains speculative until the courts render a decision.

BNewsO Editorial Note

Reviewed by our human editorial desk before publication.

#Technology&AI #BNewsO #Breaking #USNews

Source: Official Feed · Published by Bd News Online